Volume 19, Number 1—January 2013
Hepatitis E Virus Genotype 4 Outbreak, Italy, 2011
|Characteristic||Case-patient 1||Case-patient 2||Case-patient 3||Case-patient 4||Case-patient 5|
|HEV isolate no.||E2104||E2105||E2107||E2111||E2115|
|Date of symptom onset||Mar 10||Mar 12||Mar 14||Apr 1||Apr 2|
|Date of first HEV Ab detection||Mar 19||Mar 23||Mar 25||Apr 11||Apr 14|
|Clinical signs, symptoms||Fatigue, jaundice, dark urine||General malaise, fatigue||Fatigue, dark urine||Jaundice||Fatigue, vomiting|
|Duration of hospitalization, d||18||25||14||13||16|
|Alanine aminotransferase, IU/L†||4,017||2,648||2,648||5,163||3,001|
|Total bilirubin, mg/dL‡||6.5||20.0||15.6||14.7||8.0|
|Hepatitis A virus IgG||Positive||Negative||Negative||Positive||Positive|
|HBV surface antigen||Negative||Negative||Negative||Negative||Negative|
|HBV core Ab||Negative||Negative||Negative||Positive||Negative|
|Hepatitis C virus Ab||Negative||Negative||Negative||Negative||Negative|
|EBV EA IgG||Negative||Negative||Negative||Negative||Negative|
|EBV VCA IgM||Negative||Negative||Negative||Negative||Negative|
*HEV, hepatitis E virus; Ab, antibody; HBV, hepatitis B virus; EBV, Epstein–Barr virus; EA, early antigen; VCA, viral capsid antigen.
†Reference range 7–34 IU/L.
‡Reference range 0.3–1.2 mg/dL.
Page created: December 20, 2012
Page updated: December 20, 2012
Page reviewed: December 20, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.